October

ERJ Podcast Eur Respir J 2011; 38: E10
Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation Agustí A., Celli B. Eur Respir J 2011; 38: 749-751
Tuberculosis in prisons: anatomy of global neglect O'Grady J., Maeurer M., Atun R., Abubakar I., Mwaba P., Bates M., Kapata N., Ferrara G., Hoelscher M., Zumla A. Eur Respir J 2011; 38: 752-754
Healthcare-associated pneumonia: meeting the yeti Ewig S., Torres A. Eur Respir J 2011; 38: 755-757
Infection and remodelling: a 21st century model of bronchiectasis? Ward C., Rydell-Törmänen K., Westergren-Thorsson G., Eriksson L.T., Walters H. Eur Respir J 2011; 38: 758-760
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Meyer K.C., Raghu G. Eur Respir J 2011; 38: 761-769
Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: a prospective European multicentre study Bridevaux P-O., Tschopp J-M., Cardillo G., Marquette C-H., Noppen M., Astoul P., Driesen P., Bolliger C.T., Froudarakis M.E., Janssen J.P. Eur Respir J 2011; 38: 770-773
Adaptive support ventilation for faster weaning in COPD: a randomised controlled trial Kirakli C., Ozdemir I., Ucar Z.Z., Cimen P., Kepil S., Ozkan S.A. Eur Respir J 2011; 38: 774-780
Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study Abdellaoui A., Préfaut C., Gouzi F., Couillard A., Coisy-Quivy M., Hugon G., Molinari N., Lafontaine T., Jonquet O., Laoudj-Chenivesse D., Hayot M. Eur Respir J 2011; 38: 781-788
Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Pera T., Zuidhof A., Valadas J., Smit M., Schoemaker R.G., Gosens R., Maarsingh H., Zaagsma J., Meurs H. Eur Respir J 2011; 38: 789-796
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD Buhl R., Dunn L.J., Disdier C., Lassen C., Amos C., Henley M., Kramer B. Eur Respir J 2011; 38: 797-803
Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence Vandenplas O., Dressel H., Wilken D., Jamart J., Heederik D., Maestrelli P., Sigsgaard T., Henneberger P., Baur X. Eur Respir J 2011; 38: 804-811
Association between domestic mould and mould components, and asthma and allergy in children: a systematic review Tischer C., Chen C-M., Heinrich J. Eur Respir J 2011; 38: 812-824
Multi-symptom asthma as an indication of disease severity in epidemiology Ekerljung L., Bossios A., Lötvall J., Olin A-C., Rönmark E., Wennergren G., Torén K., Lundbäck B. Eur Respir J 2011; 38: 825-832
Toll-like receptors and microbial exposure: gene–gene and gene–environment interaction in the development of atopy Reijmerink N.E., Kerkhof M., Bottema R.W.B., Gerritsen J., Stelma F.F., Thijs C., van Schayck C.P., Smit H.A., Brunekreef B., Postma D.S., Koppelman G.H. Eur Respir J 2011; 38: 833-840
Role of Rho kinase isoforms in murine allergic airway responses Zhu M., Liu P-Y., Kasahara D.I., Williams A.S., Verbout N.G., Halayko A.J., Fedulov A., Shoji T., Williams E.S., Noma K., Shore S.A., Liao J.K. Eur Respir J 2011; 38: 841-850
Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment Hall S.M., Davie N., Klein N., Haworth S.G. Eur Respir J 2011; 38: 851-860
Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred Ono S., Tanaka T., Ishida M., Kinoshita A., Fukuoka J., Takaki M., Sakamoto N., Ishimatsu Y., Kohno S., Hayashi T., Senba M., Yasunami M., Kubo Y., Yoshida L.M., Kubo H., Ariyoshi K., Yoshiura K., Morimoto K. Eur Respir J 2011; 38: 861-869
Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats Tarasiuk A., Berdugo-Boura N., Troib A., Segev Y. Eur Respir J 2011; 38: 870-877
Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Attridge R.T., Frei C.R., Restrepo M.I., Lawson K.A., Ryan L., Pugh M.J.V., Anzueto A., Mortensen E.M. Eur Respir J 2011; 38: 878-887
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience Pranger A.D., van Altena R., Aarnoutse R.E., van Soolingen D., Uges D.R.A., Kosterink J.G.W., van der Werf T.S., Alffenaar J.W.C. Eur Respir J 2011; 38: 888-894
Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country Langlois-Klassen D., Wooldrage K.M., Manfreda J., Sutherland K., Ellis E., Phypers M., Gushulak B., Long R. Eur Respir J 2011; 38: 895-902
Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer Sriram K.B., Tan M.E., Savarimuthu S.M., Wright C.M., Relan V., Stockwell R.E., Clarke B.E., Duhig E.E., Yang I.A., Bowman R.V., Fong K.M. Eur Respir J 2011; 38: 903-910
Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS–FNA cytological samples Wallace W.A.H., Rassl D.M. Eur Respir J 2011; 38: 911-917
Computed tomography score and pulmonary function in infants with chronic lung disease of infancy Sarria E.E., Mattiello R., Rao L., Wanner M.R., Raske M.E., Tiller C., Kimmel R., Tepper R.S. Eur Respir J 2011; 38: 918-923
The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema Wauters E., Smeets D., Coolen J., Verschakelen J., De Leyn P., Decramer M., Vansteenkiste J., Janssens W., Lambrechts D. Eur Respir J 2011; 38: 924-931
In utero cigarette smoke exposure impairs somatic and lung growth in BALB/c mice Larcombe A.N., Foong R.E., Berry L.J., Zosky G.R., Sly P.D. Eur Respir J 2011; 38: 932-938
Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo Martin C., Thévenot G., Danel S., Chapron J., Tazi A., Macey J., Dusser D.J., Fajac I., Burgel P-R. Eur Respir J 2011; 38: 939-946
Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? Bush A., Pedersen S., Hedlin G., Baraldi E., Barbato A., de Benedictis F., Lødrup Carlsen K.C., de Jongste J., Piacentini G. Eur Respir J 2011; 38: 947-958
Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair Davey A., McAuley D.F., O'Kane C.M. Eur Respir J 2011; 38: 959-970
Strategies of muscle training in very severe COPD patients Vogiatzis I. Eur Respir J 2011; 38: 971-975
Assessing an outbreak of tuberculosis in an English college population Abubakar I., Matthews T., Harmer D., Okereke E., Crawford K., Hall T., Collyns T., Smith G., Barrett A., Baugh S. Eur Respir J 2011; 38: 976-978
Sputum induction in severe exacerbations of asthma: safety of a modified method Vieira M.O., Pizzichini E., Marques Steidle L.J., Kadletz da Silva J., Pizzichini M.M.M. Eur Respir J 2011; 38: 979-980
Interleukin-18 and interleukin-18 receptor-? expression in allergic asthma Imaoka H., Gauvreau G.M., Watson R.M., Smith S.G., Dua B., Baatjes A.J., Howie K., Hoshino T., Killian K.J., Aizawa H., O’Byrne P.M. Eur Respir J 2011; 38: 981-983
Pulmonary malakoplakia: a rare presentation mimicking extensive stage IV lung cancer Mandal P., Wallace W.A., Skwarski K.M. Eur Respir J 2011; 38: 983-985
Interstitial lung disease in a child heterozygous for the 1549C?GAA (121ins2) mutation of surfactant protein B Rossi F.P., Salerno T., Peca D., Danhaive O., Boldrini R., Menchini L., Cutrera R. Eur Respir J 2011; 38: 985-987
Ambulatory oxygen in interstitial lung disease Visca D., Montgomery A., de Lauretis A., Sestini P., Soteriou H., Maher T.M., Wells A.U., Renzoni E.A. Eur Respir J 2011; 38: 987-990
Another view on the prediction of outcomes in patients with community-acquired pneumonia Krüger S., Welte T., Ewig S. Eur Respir J 2011; 38: 991-992
Another view on the prediction of outcomes in patients with community-acquired pneumonia Schuetz P., Zimmerli W., Mueller B. Eur Respir J 2011; 38: 992-993
Asthma nervosum Papagiannis A. Eur Respir J 2011; 38: 994
Respiratory Chlamydophyla pneumoniae resides primarily in the lower airway Webley W.C., Hahn D.L. Eur Respir J 2011; 38: 994-995
Respiratory Chlamydophyla pneumoniae resides primarily in the lower airway Wang F., Gibson P.G. Eur Respir J 2011; 38: 995
“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69. Eur Respir J 2011; 38: 996